DOLUTEGRAVIR/RILPIVIRINE (Juluca®)

Clinical Indication

HIV-1 in adults

Date of classification

June 2020

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.